South Africa Lumasiran Market (2025-2031) | Share, Outlook, Value, Forecast, Growth, Segmentation, Size & Revenue, Industry, Trends, Companies, Competitive Landscape, Analysis

2.1 Key Highlights of the Report

2.2 Report Description

2.3 Market Scope & Segmentation

2.4 Research Methodology

2.5 Assumptions

3.1 South Africa Country Macro Economic Indicators

3.2 South Africa Lumasiran Market Revenues & Volume, 2021 & 2031F

3.3 South Africa Lumasiran Market - Industry Life Cycle

3.4 South Africa Lumasiran Market - Porter's Five Forces

3.5 South Africa Lumasiran Market Revenues & Volume Share, By Drug Class, 2021 & 2031F

3.6 South Africa Lumasiran Market Revenues & Volume Share, By Application, 2021 & 2031F

3.7 South Africa Lumasiran Market Revenues & Volume Share, By Dosage form, 2021 & 2031F

3.8 South Africa Lumasiran Market Revenues & Volume Share, By Route of Administration, 2021 & 2031F

3.9 South Africa Lumasiran Market Revenues & Volume Share, By End-Users, 2021 & 2031F

3.10 South Africa Lumasiran Market Revenues & Volume Share, By Distribution Channel, 2021 & 2031F

4.1 Impact Analysis

4.2 Market Drivers

4.2.1 Increasing prevalence of rare diseases in South Africa

4.2.2 Rising awareness and adoption of advanced biopharmaceutical treatments

4.2.3 Supportive government initiatives and policies promoting healthcare access and innovation

4.3 Market Restraints

4.3.1 High costs associated with lumasiran treatment

4.3.2 Limited healthcare infrastructure and resources in certain regions of South Africa

4.3.3 Regulatory challenges and approval process for new pharmaceutical products

6.1 South Africa Lumasiran Market, By Drug Class

6.1.1 Overview and Analysis

6.1.2 South Africa Lumasiran Market Revenues & Volume, By Drug Class, 2021- 2031F

6.1.3 South Africa Lumasiran Market Revenues & Volume, By Miscellaneous Metabolic Agents, 2021- 2031F

6.1.4 South Africa Lumasiran Market Revenues & Volume, By others, 2021- 2031F

6.2 South Africa Lumasiran Market, By Application

6.2.1 Overview and Analysis

6.2.2 South Africa Lumasiran Market Revenues & Volume, By Primary Hyperoxaluria, 2021- 2031F

6.2.3 South Africa Lumasiran Market Revenues & Volume, By Others, 2021- 2031F

6.3 South Africa Lumasiran Market, By Dosage form

6.3.1 Overview and Analysis

6.3.2 South Africa Lumasiran Market Revenues & Volume, By Injection, 2021- 2031F

6.3.3 South Africa Lumasiran Market Revenues & Volume, By Solution, 2021- 2031F

6.4 South Africa Lumasiran Market, By Route of Administration

6.4.1 Overview and Analysis

6.4.2 South Africa Lumasiran Market Revenues & Volume, By Subcutaneous, 2021- 2031F

6.4.3 South Africa Lumasiran Market Revenues & Volume, By Demographic, 2021- 2031F

6.4.4 South Africa Lumasiran Market Revenues & Volume, By Adult, 2021- 2031F

6.4.5 South Africa Lumasiran Market Revenues & Volume, By Pediatric, 2021- 2031F

6.5 South Africa Lumasiran Market, By End-Users

6.5.1 Overview and Analysis

6.5.2 South Africa Lumasiran Market Revenues & Volume, By Clinics, 2021- 2031F

6.5.3 South Africa Lumasiran Market Revenues & Volume, By Hospitals, 2021- 2031F

6.5.4 South Africa Lumasiran Market Revenues & Volume, By Diagnostic center, 2021- 2031F

6.6 South Africa Lumasiran Market, By Distribution Channel

6.6.1 Overview and Analysis

6.6.2 South Africa Lumasiran Market Revenues & Volume, By Hospital Pharmacy, 2021- 2031F

6.6.3 South Africa Lumasiran Market Revenues & Volume, By Retail Pharmacy, 2021- 2031F

6.6.4 South Africa Lumasiran Market Revenues & Volume, By Online Pharmacy, 2021- 2031F

7.1 South Africa Lumasiran Market Export to Major Countries

7.2 South Africa Lumasiran Market Imports from Major Countries

8.1 Patient enrollment in clinical trials for lumasiran

8.2 Number of healthcare professionals trained in administering lumasiran treatment

8.3 Patient adherence and compliance rates to lumasiran therapy

8.4 Rate of adverse events reported for lumasiran treatment

8.5 Level of reimbursement coverage for lumasiran therapy by healthcare insurers

9.1 South Africa Lumasiran Market Opportunity Assessment, By Drug Class, 2021 & 2031F

9.2 South Africa Lumasiran Market Opportunity Assessment, By Application, 2021 & 2031F

9.3 South Africa Lumasiran Market Opportunity Assessment, By Dosage form, 2021 & 2031F

9.4 South Africa Lumasiran Market Opportunity Assessment, By Route of Administration, 2021 & 2031F

9.5 South Africa Lumasiran Market Opportunity Assessment, By End-Users, 2021 & 2031F

9.6 South Africa Lumasiran Market Opportunity Assessment, By Distribution Channel, 2021 & 2031F

10.1 South Africa Lumasiran Market Revenue Share, By Companies, 2024

10.2 South Africa Lumasiran Market Competitive Benchmarking, By Operating and Technical Parameters